comparemela.com

Latest Breaking News On - Medicinal chemistry - Page 1 : comparemela.com

New chelating agent reduces toxicity in prostate-specific membrane antigen radiopharmaceutical therapy

A newly developed chelator can significantly reduce off-target toxicity in prostate-specific membrane antigen (PSMA) radiopharmaceutical therapy, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting. By improving the bond between the radioactive metal ion and the PSMA-targeting antibody, the chelator can make PSMA therapy safer and more effective for patients.

How HHC Helped My Anxiety vs Delta-9 Products: Benefits of HHC Supported By Science

University of Oxford research receives £5 million funding boost from British Heart Foundation

University of Oxford research receives £5 million funding boost from British Heart Foundation
indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.